<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33546322</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>03</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>A Crucial Role of ACBD3 Required for Coxsackievirus Infection in Animal Model Developed by AAV-Mediated CRISPR Genome Editing Technique.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13020237</ELocationID><Abstract><AbstractText>Genetic screens using CRISPR/Cas9 have been exploited to discover host-virus interactions. These screens have identified viral dependencies on host proteins during their life cycle and potential antiviral strategies. The acyl-CoA binding domain containing 3 (ACBD3) was identified as an essential host factor for the Coxsackievirus B3 (CVB3) infection. Other groups have also investigated the role of ACBD3 as a host factor for diverse enteroviruses in cultured cells. However, it has not been tested if ACBD3 is required in the animal model of CVB3 infection. Owing to embryonic lethality, conventional knockout mice were not available for in vivo study. As an alternative approach, we used adeno-associated virus (AAV)-mediated CRISPR genome editing to generate mice that lacked ACBD3 within the pancreas, the major target organ for CVB3. Delivery of sgRNAs using self-complementary (sc) AAV8 efficiently induced a loss-of-function mutation in the pancreas of the Cas9 knock-in mice. Loss of ACBD3 in the pancreas resulted in a 100-fold reduction in the CVB3 titer within the pancreas and a noticeable reduction in viral protein expression. These results indicate a crucial function of ACBD3 in CVB3 infection in vivo. AAV-mediated CRISPR genome editing may be applicable to many in vivo studies on the virus-host interaction and identify a novel target for antiviral therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hye Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku</LastName><ForeName>Keun Bon</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Soojin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4700-8627</Identifier><AffiliationInfo><Affiliation>Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Heon Seok</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yeon-Soo</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Bum-Tae</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seong-Jun</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0001-8504-2872</Identifier><AffiliationInfo><Affiliation>Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chonsaeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486730">Acbd3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064112" MajorTopicYN="Y">Clustered Regularly Interspaced Short Palindromic Repeats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="N">Dependovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACBD3</Keyword><Keyword MajorTopicYN="N">Cas9 TG mouse</Keyword><Keyword MajorTopicYN="N">adeno-associated virus</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">in vivo genome editing</Keyword></KeywordList><CoiStatement>There are no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>6</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33546322</ArticleId><ArticleId IdType="pmc">PMC7913485</ArticleId><ArticleId IdType="doi">10.3390/v13020237</ArticleId><ArticleId IdType="pii">v13020237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cho S.W., Kim S., Kim J.M., Kim J.S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 2013;31:230&#x2013;232. doi: 10.1038/nbt.2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2507</ArticleId><ArticleId IdType="pubmed">23360966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819&#x2013;823. doi: 10.1126/science.1231143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1231143</ArticleId><ArticleId IdType="pmc">PMC3795411</ArticleId><ArticleId IdType="pubmed">23287718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science. 2013;339:823&#x2013;826. doi: 10.1126/science.1232033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232033</ArticleId><ArticleId IdType="pmc">PMC3712628</ArticleId><ArticleId IdType="pubmed">23287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike-Yusa H., Li Y., Tan E.P., Velasco-Herrera Mdel C., Yusa K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 2014;32:267&#x2013;273. doi: 10.1038/nbt.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2800</ArticleId><ArticleId IdType="pubmed">24535568</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalem O., Sanjana N.E., Hartenian E., Shi X., Scott D.A., Mikkelson T., Heckl D., Ebert B.L., Root D.E., Doench J.G., et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343:84&#x2013;87. doi: 10.1126/science.1247005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1247005</ArticleId><ArticleId IdType="pmc">PMC4089965</ArticleId><ArticleId IdType="pubmed">24336571</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Rodriguez D.R., Ramirez-Solis R., Garza-Elizondo M.A., Garza-Rodriguez M.L., Barrera-Saldana H.A. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review) Int. J. Mol. Med. 2019;43:1559&#x2013;1574. doi: 10.3892/ijmm.2019.4112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2019.4112</ArticleId><ArticleId IdType="pmc">PMC6414166</ArticleId><ArticleId IdType="pubmed">30816503</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrock E., Guell M. CRISPR in Animals and Animal Models. Prog. Mol. Biol. Transl. Sci. 2017;152:95&#x2013;114. doi: 10.1016/bs.pmbts.2017.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2017.07.010</ArticleId><ArticleId IdType="pubmed">29150007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C.L., Ruan M.Z.C., Mahajan V.B., Tsang S.H. Viral Delivery Systems for CRISPR. Viruses. 2019;11:28. doi: 10.3390/v11010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010028</ArticleId><ArticleId IdType="pmc">PMC6356701</ArticleId><ArticleId IdType="pubmed">30621179</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander I.E., Russell D.W., Spence A.M., Miller A.D. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 1996;7:841&#x2013;850. doi: 10.1089/hum.1996.7.7-841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.1996.7.7-841</ArticleId><ArticleId IdType="pubmed">8860836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakai H., Yant S.R., Storm T.A., Fuess S., Meuse L., Kay M.A. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 2001;75:6969&#x2013;6976. doi: 10.1128/JVI.75.15.6969-6976.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.15.6969-6976.2001</ArticleId><ArticleId IdType="pmc">PMC114425</ArticleId><ArticleId IdType="pubmed">11435577</ArticleId></ArticleIdList></Reference><Reference><Citation>High K.A., Roncarolo M.G. Gene Therapy. N. Engl. J. Med. 2019;381:455&#x2013;464. doi: 10.1056/NEJMra1706910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1706910</ArticleId><ArticleId IdType="pubmed">31365802</ArticleId></ArticleIdList></Reference><Reference><Citation>Senis E., Fatouros C., Grosse S., Wiedtke E., Niopek D., Mueller A.K., Borner K., Grimm D. CRISPR/Cas9-mediated genome engineering: An adeno-associated viral (AAV) vector toolbox. Biotechnol. J. 2014;9:1402&#x2013;1412. doi: 10.1002/biot.201400046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biot.201400046</ArticleId><ArticleId IdType="pubmed">25186301</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty D.M., Fu H., Monahan P.E., Toulson C.E., Naik P., Samulski R.J. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 2003;10:2112&#x2013;2118. doi: 10.1038/sj.gt.3302134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gt.3302134</ArticleId><ArticleId IdType="pubmed">14625565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Ma H.I., Li J., Sun L., Zhang J., Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 2003;10:2105&#x2013;2111. doi: 10.1038/sj.gt.3302133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gt.3302133</ArticleId><ArticleId IdType="pubmed">14625564</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty D.M. Self-complementary AAV vectors; advances and applications. Mol. Ther. J. Am. Soc. Gene Ther. 2008;16:1648&#x2013;1656. doi: 10.1038/mt.2008.171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2008.171</ArticleId><ArticleId IdType="pubmed">18682697</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R.J., Chen S., Zhou Y., Yim M.J., Swiech L., Kempton H.R., Dahlman J.E., Parnas O., Eisenhaure T.M., Jovanovic M., et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159:440&#x2013;455. doi: 10.1016/j.cell.2014.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.014</ArticleId><ArticleId IdType="pmc">PMC4265475</ArticleId><ArticleId IdType="pubmed">25263330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschaharganeh D.F., Lowe S.W., Garippa R.J., Livshits G. Using CRISPR/Cas to study gene function and model disease in vivo. FEBS J. 2016;283:3194&#x2013;3203. doi: 10.1111/febs.13750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13750</ArticleId><ArticleId IdType="pmc">PMC5120361</ArticleId><ArticleId IdType="pubmed">27149548</ArticleId></ArticleIdList></Reference><Reference><Citation>McDougall W.M., Perreira J.M., Reynolds E.C., Brass A.L. CRISPR genetic screens to discover host-virus interactions. Curr. Opin. Virol. 2018;29:87&#x2013;100. doi: 10.1016/j.coviro.2018.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2018.03.007</ArticleId><ArticleId IdType="pubmed">29684735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.S., Lee K., Bae S., Park J., Lee C.K., Kim M., Kim E., Kim S., Kim C., Kim J.S. CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection. J. Biol. Chem. 2017;292:10664&#x2013;10671. doi: 10.1074/jbc.M117.782425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.782425</ArticleId><ArticleId IdType="pmc">PMC5481571</ArticleId><ArticleId IdType="pubmed">28446605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.S., Lee K., Kim S.J., Cho S., Shin H.J., Kim C., Kim J.S. Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection. Genome Res. 2018;28:859&#x2013;868. doi: 10.1101/gr.230250.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.230250.117</ArticleId><ArticleId IdType="pmc">PMC5991512</ArticleId><ArticleId IdType="pubmed">29712754</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoule F., Brisac C., Pelletier I., Vidalain P.O., Jegouic S., Mirabelli C., Bessaud M., Combelas N., Autret A., Tangy F., et al. The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication. J. Virol. 2013;87:11031&#x2013;11046. doi: 10.1128/JVI.00304-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00304-13</ArticleId><ArticleId IdType="pmc">PMC3807280</ArticleId><ArticleId IdType="pubmed">23926333</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu C.M., van der Schaar H.M., Ford L.A., Strating J.R., Ulferts R., Fang Y., Belov G., van Kuppeveld F.J. Recruitment of PI4KIIIbeta to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1. J. Virol. 2014;88:2725&#x2013;2736. doi: 10.1128/JVI.03650-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03650-13</ArticleId><ArticleId IdType="pmc">PMC3958084</ArticleId><ArticleId IdType="pubmed">24352456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Zhang Z., Ma Y., Qi J., Wu C., Xiao Y., Zhou Z., He B., Wang J. The Golgi protein ACBD3 facilitates Enterovirus 71 replication by interacting with 3A. Sci. Rep. 2017;7:44592. doi: 10.1038/srep44592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44592</ArticleId><ArticleId IdType="pmc">PMC5356004</ArticleId><ArticleId IdType="pubmed">28303920</ArticleId></ArticleIdList></Reference><Reference><Citation>Horova V., Lyoo H., Rozycki B., Chalupska D., Smola M., Humpolickova J., Strating J., van Kuppeveld F.J.M., Boura E., Klima M. Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites. PLoS Pathog. 2019;15:e1007962. doi: 10.1371/journal.ppat.1007962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007962</ArticleId><ArticleId IdType="pmc">PMC6695192</ArticleId><ArticleId IdType="pubmed">31381608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo H., van der Schaar H.M., Dorobantu C.M., Rabouw H.H., Strating J., van Kuppeveld F.J.M. ACBD3 Is an Essential Pan-enterovirus Host Factor That Mediates the Interaction between Viral 3A Protein and Cellular Protein PI4KB. mBio. 2019;10 doi: 10.1128/mBio.02742-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02742-18</ArticleId><ArticleId IdType="pmc">PMC6372799</ArticleId><ArticleId IdType="pubmed">30755512</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki J., Ishikawa K., Arita M., Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 2012;31:754&#x2013;766. doi: 10.1038/emboj.2011.429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.429</ArticleId><ArticleId IdType="pmc">PMC3273392</ArticleId><ArticleId IdType="pubmed">22124328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard N.L., Zhang L., Chen J.W., Guttenberg M., Sanchez M.D., Bergelson J.M. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe. 2009;6:91&#x2013;98. doi: 10.1016/j.chom.2009.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.05.018</ArticleId><ArticleId IdType="pmc">PMC2761025</ArticleId><ArticleId IdType="pubmed">19616768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J. Mouse knockout models for HIV-1 restriction factors. Cell. Mol. Life Sci. CMLS. 2014;71:3749&#x2013;3766. doi: 10.1007/s00018-014-1646-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1646-8</ArticleId><ArticleId IdType="pmc">PMC4160573</ArticleId><ArticleId IdType="pubmed">24854580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnow C., Engels G., Arendt A., Schwalm F., Sediri H., Preuss A., Nelson P.S., Garten W., Klenk H.D., Gabriel G., et al. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J. Virol. 2014;88:4744&#x2013;4751. doi: 10.1128/JVI.03799-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03799-13</ArticleId><ArticleId IdType="pmc">PMC3993819</ArticleId><ArticleId IdType="pubmed">24522916</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Y., Yan Y., Tan K.S., Tan S.S.L., Seet J.E., Arumugam T.V., Chow V.T.K., Wang Y., Tran T. CD151, a novel host factor of nuclear export signaling in influenza virus infection. J. Allergy Clin. Immunol. 2018;141:1799&#x2013;1817. doi: 10.1016/j.jaci.2017.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.11.032</ArticleId><ArticleId IdType="pubmed">29274410</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Liu J., Culty M., Papadopoulos V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): An emerging signaling molecule. Prog. Lipid Res. 2010;49:218&#x2013;234. doi: 10.1016/j.plipres.2009.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2009.12.003</ArticleId><ArticleId IdType="pmc">PMC2873055</ArticleId><ArticleId IdType="pubmed">20043945</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena I., Fischer C., Gebhard J.R., Perry C.M., Harkins S., Whitton J.L. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology. Virology. 2000;271:276&#x2013;288. doi: 10.1006/viro.2000.0332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0332</ArticleId><ArticleId IdType="pubmed">10860882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Zhu T., Rehman K.K., Bertera S., Zhang J., Chen C., Papworth G., Watkins S., Trucco M., Robbins P.D., et al. Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. Diabetes. 2006;55:875&#x2013;884. doi: 10.2337/diabetes.55.04.06.db05-0927.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.55.04.06.db05-0927</ArticleId><ArticleId IdType="pubmed">16567506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.K., Yun S.H., Ju E.S., Kim B.K., Lee Y.J., Yoo D.K., Kim Y.C., Jeon E.S. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model. Virus Res. 2015;199:1&#x2013;8. doi: 10.1016/j.virusres.2014.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.11.030</ArticleId><ArticleId IdType="pubmed">25485472</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Bae S., Kim J.S. Cas-Designer: A web-based tool for choice of CRISPR-Cas9 target sites. Bioinformatics. 2015;31:4014&#x2013;4016. doi: 10.1093/bioinformatics/btv537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv537</ArticleId><ArticleId IdType="pubmed">26358729</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S.W., Kim S., Kim Y., Kweon J., Kim H.S., Bae S., Kim J.S. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 2014;24:132&#x2013;141. doi: 10.1101/gr.162339.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.162339.113</ArticleId><ArticleId IdType="pmc">PMC3875854</ArticleId><ArticleId IdType="pubmed">24253446</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Lim K., Kim J.S., Bae S. Cas-analyzer: An online tool for assessing genome editing results using NGS data. Bioinformatics. 2017;33:286&#x2013;288. doi: 10.1093/bioinformatics/btw561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw561</ArticleId><ArticleId IdType="pmc">PMC5254075</ArticleId><ArticleId IdType="pubmed">27559154</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Park J.B., Bae P.K., Kim H.S., Kim D.W., Ahn J.K., Lee C.K. Establishment and use of a cell line expressing HSV-1 thymidine kinase to characterize viral thymidine kinase-dependent drug-resistance. Antivir. Res. 2002;54:163&#x2013;174. doi: 10.1016/S0166-3542(01)00221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(01)00221-2</ArticleId><ArticleId IdType="pubmed">12062389</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L.J., Muench H. A Simple Method of Estimating Fifty per cent Endpoints. Am. J. Epidemiol. 1938;27:493&#x2013;497. doi: 10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H., Kim C., Kim D.E., Song J.H., Choi M., Choi K., Kang M., Lee K., Kim H.S., Shin J.S., et al. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses. Antivir. Res. 2015;124:1&#x2013;10. doi: 10.1016/j.antiviral.2015.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.10.011</ArticleId><ArticleId IdType="pubmed">26526589</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L., DeRisi J.L. ACBD3 interaction with TBC1 domain 22 protein is differentially affected by enteroviral and kobuviral 3A protein binding. mBio. 2013;4:e00098-13. doi: 10.1128/mBio.00098-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00098-13</ArticleId><ArticleId IdType="pmc">PMC3622926</ArticleId><ArticleId IdType="pubmed">23572552</ArticleId></ArticleIdList></Reference><Reference><Citation>Klima M., Toth D.J., Hexnerova R., Baumlova A., Chalupska D., Tykvart J., Rezabkova L., Sengupta N., Man P., Dubankova A., et al. Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein. Sci. Rep. 2016;6:23641. doi: 10.1038/srep23641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23641</ArticleId><ArticleId IdType="pmc">PMC4806292</ArticleId><ArticleId IdType="pubmed">27009356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X., Qian Y., Gim B., Lee I. Acyl-CoA-Binding Domain-Containing 3 (ACBD3; PAP7; GCP60): A Multi-Functional Membrane Domain Organizer. Int. J. Mol. Sci. 2019;20:2028. doi: 10.3390/ijms20082028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20082028</ArticleId><ArticleId IdType="pmc">PMC6514682</ArticleId><ArticleId IdType="pubmed">31022988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta M., Robertson S.J., Okumura A., Scott D.P., Chang J., Weiss J.M., Sturdevant G.L., Feldmann F., Haddock E., Chiramel A.I., et al. A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection. Cell Rep. 2017;18:816&#x2013;829. doi: 10.1016/j.celrep.2016.12.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.12.069</ArticleId><ArticleId IdType="pmc">PMC5289750</ArticleId><ArticleId IdType="pubmed">28099857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurumurthy C.B., Lloyd K.C.K. Generating mouse models for biomedical research: Technological advances. Dis. Models Mech. 2019;12 doi: 10.1242/dmm.029462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029462</ArticleId><ArticleId IdType="pmc">PMC6361157</ArticleId><ArticleId IdType="pubmed">30626588</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>